category,label,placebo,placebo_pct,xanomeline_ld,xanomeline_ld_pct,xanomeline_hd,xanomeline_hd_pct,p
Week 8,n,77,,81,,73,,0.27272727272
,Marked improvement,0,,0,,0,,
,Moderate improvement,1,1,2,2,1,1,
,Minimal improvement,19,25,16,20,13,18,
,No Change,45,58,48,59,38,52,
,Minimal worsening,10,13,14,17,20,27,
,Moderate worsening,2,3,1,1,1,1,
,Marked worsening,0,,0,,0,,
,,,,,,,,
Week 16,n,79,,81,,74,,0.4003023
,Marked improvement,0,,0,,0,,
,Moderate improvement,0,,3,4,2,3,
,Minimal improvement,12,15,12,15,13,18,
,No Change,41,52,46,57,39,53,
,Minimal worsening,25,32,19,23,20,27,
,Moderate worsening,1,1,1,1,0,,
,Marked worsening,0,,0,,0,,
,,,,,,,,
Week 24,n,79,,81,,74,,0.618321
,Marked improvement,0,,0,,0,,
,Moderate improvement,1,1,1,1,0,,
,Minimal improvement,9,11,14,17,11,15,
,No Change,38,48,37,46,33,45,
,Minimal worsening,28,35,27,33,25,34,
,Moderate worsening,3,4,2,2,5,7,
,Marked worsening,0,,0,,0,,